Vitalhub Corp. (TSE:VHI) Given Consensus Rating of “Buy” by Analysts

Vitalhub Corp. (TSE:VHI) has received an average recommendation of “Buy” from the seven research firms that are currently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is C$13.00.

A number of brokerages have weighed in on VHI. National Bank Financial decreased their target price on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating for the company in a research report on Wednesday, May 27th. Canaccord Genuity Group set a C$15.00 price objective on shares of Vitalhub and gave the company a “buy” rating in a research report on Friday, August 28th.

Vitalhub Stock Performance

Shares of Vitalhub stock opened at C$7.66 on Tuesday. The stock has a market capitalization of C$485.18 million, a PE ratio of 63.83, a price-to-earnings-growth ratio of 1.18 and a beta of 1.14. Vitalhub has a 52-week low of C$6.46 and a 52-week high of C$11.91. The company has a 50-day simple moving average of C$7.54 and a two-hundred day simple moving average of C$7.50.

Vitalhub (TSE:VHI) last announced its quarterly earnings results on Thursday, August 6th. The company reported C$0.03 earnings per share for the quarter. The company had revenue of C$31.74 million during the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. As a group, equities research analysts forecast that Vitalhub will post 0.2296467 EPS for the current fiscal year.

Vitalhub Company Profile

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.